Optometrists in Tecumseh, OK Accepting Medicare
4 Optometrists found. Showing 1 - 4
 Tecumseh Eye Associates Pllc Optometrist Medicare: Medicare Enrolled Practice Location: 123 E Washington St, Tecumseh, OK 74873 Phone: 405-598-6558 Fax: 405-598-2202 |
 Kyle Karnish, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 123 E Washington St, Tecumseh, OK 74873 Phone: 405-598-6558 |
 Candace Acord, O.D.L Optometrist Medicare: Accepting Medicare Assignments Practice Location: 123 E Washington St, Tecumseh, OK 74873 Phone: 405-598-6558 Fax: 405-598-2202 |
Harrah Eye Clinic Optometrist Medicare: Not Enrolled in Medicare Practice Location: 123 E Washington St, Tecumseh, OK 74873 Phone: 405-598-6558 |
News Archive
Obese women may get less dangerous form of preeclampsia, study suggests
Despite having higher rates of preeclampsia, a dangerous high-blood pressure disorder of late pregnancy, obese women may be less than half as likely to suffer strokes, seizures, and other serious complications of the disorder. The
Southern African health officials develop cross-border initiative for malaria elimination
Health ministers from eight countries in the Southern African Development Community this week held a Malaria Elimination Ministerial Meeting in the Namibian capital of Windhoek to develop a cross-border approach for eliminating malaria in the region, New Era reports.
Human neutralizing antibody pair blocks COVID-19-ACE2 binding
With the ongoing COVID-19 pandemic carving its deadly path across the world, and no end in sight in the immediate future, researchers are working furiously to bring out an effective therapeutic drug or vaccine that will stop the virus in its tracks.
Use of next-generation gene sequencing in NICUs may improve diagnosis of rare diseases
The use of next-generation gene sequencing in newborns in neonatal intensive care units (NICUs) may improve the diagnosis of rare diseases and deliver results more quickly to anxious families, according to new research in CMAJ (Canadian Medical Association Journal).
Abbvie's HOLKIRA PAK for chronic genotype 1 Hepatitis C treatment receives Health Canada approval
AbbVie receives Health Canada approval for HOLKIRA PAK (ombitasvir/paritaprevir/ritonavir film-coated tablets; dasabuvir film-coated tablets), an all-oral, short-course (12 weeks for the majority of patients), interferon-free treatment, with or without ribavirin (RBV), for the treatment of patients with genotype 1 (GT1) chronic hepatitis C virus (HCV) infection, including those with cirrhosis.
› Verified 4 days ago